# A Study of LY2409021 Formulations and the Effect of Food

> **NCT01354496** · PHASE1 · COMPLETED · sponsor: **Eli Lilly and Company** · enrollment: 35 (actual)

## Conditions studied

- Healthy Volunteers

## Interventions

- **DRUG:** LY2409021 Reference Form
- **DRUG:** LY2409021 Test-Med Formulation (medium particle size)
- **DRUG:** LY2409021 Test-High Formulation (high particle size)
- **DRUG:** LY2409021 Test-Low Formulation (low particle size)

## Key facts

- **NCT ID:** NCT01354496
- **Lead sponsor:** Eli Lilly and Company
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-04
- **Primary completion:** 2011-10
- **Final completion:** 2011-10
- **Target enrollment:** 35 (ACTUAL)
- **Last updated:** 2019-03-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01354496

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01354496, "A Study of LY2409021 Formulations and the Effect of Food". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01354496. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*